CD8A and neoplasm: In this study, among the 30 tumors that recurred in lymph nodes and/or distant organs, those in patients in whom the primary tumor had higher B7-H4 and lower CD8 expression showed a poorer response to first-line platinum-based chemotherapy than these with lower B7-H4 and higher CD8 expression.